How Amgen Delivered a New Rare Disease Therapy
June 2, 2025
We speak with experts from Amgen and Henry Ford Health about the development and approval of Uplizna for IgG4-related disease.
9 min read
Interviews
A Career of Antibody Drug Conjugates
By Stephanie Vine
May 30, 2025
From different modalities to overcoming aggregation; we find out what advances are affecting the development of ADCs.
3 min read
Behind the Scenes of a GMP Win
May 29, 2025
We ask a company about lessons learned from the GMP certification process.
4 min read
The New Age of Global, Political, and Regulatory Challenges
May 28, 2025
A report attempts to unravel the many challenges that face business leaders. We discuss those inherent in – and unique to – the pharmaceutical industry, from supply chains to tariffs, and more.
7 min read
What Trump’s Latest Moves Mean for the Industry
May 27, 2025
Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.
6 min read
Pharma Braces for Economic Downturn
May 22, 2025
We ask an analyst how pharma companies can weather the volatile economic environment and the Trump administration’s tariffs.
4 min read
Life Through A Scientific Lens
May 20, 2025
From academia in Milan to professional development in the UK with Pfizer and Johnson & Johnson Innovation, Valo Therapeutics CEO Marcella Origgi shares her journey.
6 min read
Measuring the Carbon Footprint of Digital Tools for Clinical Trials
May 12, 2025
Can digital tools help lower the carbon footprint of a clinical trial? First, we need more data.
5 min read
The Trump Effect on Biopharma: FDA Disruption, Tariffs, and Funding Cuts
May 9, 2025
Trump continues to send shockwaves through the industry. We look at FDA disruption, tariffs, funding volatility, and more.
5 min read
